Cargando…

Cardiovascular Disease-Associated MicroRNAs as Novel Biomarkers of First-Trimester Screening for Gestational Diabetes Mellitus in the Absence of Other Pregnancy-Related Complications

We assessed the diagnostic potential of cardiovascular disease-associated microRNAs for the early prediction of gestational diabetes mellitus (GDM) in singleton pregnancies of Caucasian descent in the absence of other pregnancy-related complications. Whole peripheral venous blood samples were collec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hromadnikova, Ilona, Kotlabova, Katerina, Krofta, Ladislav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501303/ https://www.ncbi.nlm.nih.gov/pubmed/36142536 http://dx.doi.org/10.3390/ijms231810635

Ejemplares similares

First Trimester Prediction of Preterm Delivery in the Absence of Other Pregnancy-Related Complications Using Cardiovascular-Disease Associated MicroRNA Biomarkers
por: Hromadnikova, Ilona, et al.
Publicado: (2022)

Novel First-Trimester Prediction Model for Any Type of Preterm Birth Occurring before 37 Gestational Weeks in the Absence of Other Pregnancy-Related Complications Based on Cardiovascular Disease-Associated MicroRNAs and Basic Maternal Clinical Characteristics
por: Hromadnikova, Ilona, et al.
Publicado: (2022)

A History of Preterm Delivery Is Associated with Aberrant Postpartal MicroRNA Expression Profiles in Mothers with an Absence of Other Pregnancy-Related Complications
por: Hromadnikova, Ilona, et al.
Publicado: (2021)

First-Trimester Screening for Fetal Growth Restriction and Small-for-Gestational-Age Pregnancies without Preeclampsia Using Cardiovascular Disease-Associated MicroRNA Biomarkers
por: Hromadnikova, Ilona, et al.
Publicado: (2022)

Cardiovascular Disease-Associated MicroRNA Dysregulation during the First Trimester of Gestation in Women with Chronic Hypertension and Normotensive Women Subsequently Developing Gestational Hypertension or Preeclampsia with or without Fetal Growth Restriction
por: Hromadnikova, Ilona, et al.
Publicado: (2022)

Diabetes Mellitus and Cardiovascular Risk Assessment in Mothers with a History of Gestational Diabetes Mellitus Based on Postpartal Expression Profile of MicroRNAs Associated with Diabetes Mellitus and Cardiovascular and Cerebrovascular Diseases
por: Hromadnikova, Ilona, et al.
Publicado: (2020)

The Prediction of Gestational Hypertension, Preeclampsia and Fetal Growth Restriction via the First Trimester Screening of Plasma Exosomal C19MC microRNAs
por: Hromadnikova, Ilona, et al.
Publicado: (2019)

First Trimester Screening of Circulating C19MC microRNAs Can Predict Subsequent Onset of Gestational Hypertension
por: Hromadnikova, Ilona, et al.
Publicado: (2014)

Substantially Altered Expression Profile of Diabetes/Cardiovascular/Cerebrovascular Disease Associated microRNAs in Children Descending from Pregnancy Complicated by Gestational Diabetes Mellitus—One of Several Possible Reasons for an Increased Cardiovascular Risk
por: Hromadnikova, Ilona, et al.
Publicado: (2020)

First-Trimester Screening for Miscarriage or Stillbirth—Prediction Model Based on MicroRNA Biomarkers
por: Hromadnikova, Ilona, et al.
Publicado: (2023)

First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR
por: Hromadnikova, Ilona, et al.
Publicado: (2017)

Cardiovascular and Cerebrovascular Disease Associated microRNAs Are Dysregulated in Placental Tissues Affected with Gestational Hypertension, Preeclampsia and Intrauterine Growth Restriction
por: Hromadnikova, Ilona, et al.
Publicado: (2015)

First-Trimester Screening for HELLP Syndrome—Prediction Model Based on MicroRNA Biomarkers and Maternal Clinical Characteristics
por: Hromadnikova, Ilona, et al.
Publicado: (2023)

Association Analysis in Children Born from Normal and Complicated Pregnancies—Cardiovascular Disease Associated microRNAs and the Incidence of Prehypertension/Hypertension, Overweight/Obesity, Valve Problems and Heart Defects
por: Hromadnikova, Ilona, et al.
Publicado: (2020)

Postnatal Expression Profile of microRNAs Associated with Cardiovascular and Cerebrovascular Diseases in Children at the Age of 3 to 11 Years in Relation to Previous Occurrence of Pregnancy-Related Complications
por: Hromadnikova, Ilona, et al.
Publicado: (2019)

Association Analysis in Young and Middle-Aged Mothers—Relation between Expression of Cardiovascular Disease Associated MicroRNAs and Abnormal Clinical Findings
por: Hromadnikova, Ilona, et al.
Publicado: (2021)

Postnatal Expression Profile of MicroRNAs Associated with Cardiovascular Diseases in 3- to 11-Year-Old Preterm-Born Children
por: Hromadnikova, Ilona, et al.
Publicado: (2021)

Maternal Cardiovascular Risk Assessment 3-to-11 Years Postpartum in Relation to Previous Occurrence of Pregnancy-Related Complications
por: Hromadnikova, Ilona, et al.
Publicado: (2019)

Evaluation of Vascular Endothelial Function in Young and Middle-Aged Women with Respect to a History of Pregnancy, Pregnancy-Related Complications, Classical Cardiovascular Risk Factors, and Epigenetics
por: Hromadnikova, Ilona, et al.
Publicado: (2020)

Expression profile of C19MC microRNAs in placental tissue of patients with preterm prelabor rupture of membranes and spontaneous preterm birth
por: Hromadnikova, Ilona, et al.
Publicado: (2017)

Circulating C19MC MicroRNAs in Preeclampsia, Gestational Hypertension, and Fetal Growth Restriction
por: Hromadnikova, Ilona, et al.
Publicado: (2013)

Circulating heat shock protein mRNA profile in gestational hypertension, pre-eclampsia & foetal growth restriction
por: Hromadnikova, Ilona, et al.
Publicado: (2016)

Extracellular chromosome 21-derived microRNAs in euploid & aneuploid pregnancies
por: Kotlabova, Katerina, et al.
Publicado: (2013)

Pathogenesis of Pregnancy-Related Complications
por: Hromadnikova, Ilona
Publicado: (2023)

Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp 70 Derived 14-Mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors on Peripheral Blood T Cells, B Cells and NKT Cells
por: Hromadnikova, Ilona, et al.
Publicado: (2016)

Pathogenesis of Pregnancy-Related Complications 1.0 and 2.0
por: Hromadnikova, Ilona
Publicado: (2022)

First-Trimester Follistatin-Like-3 Levels in Pregnancies Complicated by Subsequent Gestational Diabetes Mellitus
por: Thadhani, Ravi, et al.
Publicado: (2010)

First-Trimester Screening for Gestational Diabetes Mellitus in Twin Pregnancies
por: Buerger, Olga, et al.
Publicado: (2021)

Characterization of Maternal Circulating MicroRNAs in Obese Pregnancies and Gestational Diabetes Mellitus
por: Serati, Anaïs, et al.
Publicado: (2023)

Association of maternal folate status in the second trimester of pregnancy with the risk of gestational diabetes mellitus
por: Xie, Kaipeng, et al.
Publicado: (2019)

Gestational weight gain targets during the second and third trimesters of pregnancy for women with gestational diabetes mellitus in China
por: Wu, Jiang-Nan, et al.
Publicado: (2018)

Urinary Metabolites Altered during the Third Trimester in Pregnancies Complicated by Gestational Diabetes Mellitus: Relationship with Potential Upcoming Metabolic Disorders
por: López-Hernández, Yamilé, et al.
Publicado: (2019)

First Trimester Plasma MicroRNA Levels Predict Risk of Developing Gestational Diabetes Mellitus
por: Légaré, Cécilia, et al.
Publicado: (2022)

Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancy
por: Luque, Ana, et al.
Publicado: (2014)

Fasting plasma glucose in the first trimester is related to gestational diabetes mellitus and adverse pregnancy outcomes
por: Tong, Jia-Ning, et al.
Publicado: (2021)

Risk Estimation of Gestational Diabetes Mellitus in the First Trimester
por: Gerszi, Dóra, et al.
Publicado: (2023)

Uric Acid and Xanthine Levels in Pregnancy Complicated by Gestational Diabetes Mellitus—The Effect on Adverse Pregnancy Outcomes
por: Pleskacova, Anna, et al.
Publicado: (2018)

MicroRNAs and Exosomal microRNAs May Be Possible Targets to Investigate in Gestational Diabetes Mellitus
por: Yang, Xiyao, et al.
Publicado: (2022)

Circulating miRNAs in the first trimester and pregnancy complications: a systematic review
por: Subramanian, Anita, et al.
Publicado: (2022)

A Big Role for microRNAs in Gestational Diabetes Mellitus
por: Masete, Matladi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nhiimn8g0t91nsdi1k8obgautq